Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Ah. Reum Lim"'
Autor:
In Mok Oh, Maeng Je Cho, Bong-Jin Hahm, Byung-Soo Kim, Jee Hoon Sohn, Hye Won Suk, Bu Young Jung, Hye Jung Kim, Hyeon A. Kim, Ki Bok Choi, Da Hye You, Ah. Reum Lim, In Ok Park, Jeung Hyuck Ahn, Hee Lee, Yeon Hee Kim, Mi Ra Kim, Jee Eun Park
Publikováno v:
BMC Geriatrics, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Although a focus on late-life depression may help preventing suicide in older adults, many older people, especially those living in rural areas, have relatively low accessibility to treatment. This study examined the feasibility a
Externí odkaz:
https://doaj.org/article/b0340f327d7a45d3ac645454b0695dce
Autor:
Ju Won Kim, Ah Reum Lim, Ji Yoon Lee, June Young Lee, Soohyeon Lee, Yoon Ji Choi, Yeol Hong Kim, Kyong Hwa Park
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Purpose Chemotherapy-induced nausea and vomiting (CINV) is a common adverse events in cancer patients and can negatively affect their quality of life (QoL). This study aimed to evaluate the clinical efficacy of an electric massage chair (EMC
Externí odkaz:
https://doaj.org/article/a9c6d46a0975427a8a39d0f2ca612f12
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Bone-modifying agents (BMA) are key components in the management of cancer patients with bone metastasis. Despite their clinical benefits, the use of BMA is associated with dental adverse events (AEs) including medication-related
Externí odkaz:
https://doaj.org/article/d206230d803f49e7bd280a2dd5f6c9bd
Autor:
Ah Reum Lim, Boyeon Kim, Jwa Hoon Kim, Myung Han Hyun, Kyong Hwa Park, Yeul Hong Kim, Soohyeon Lee
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThis phase Ib study was performed to determine the safety of combination capecitabine with alpleisib (phosphatidylinositol 3-kinase catalytic subunit p110α blockade) and determine the maximal tolerated dose (MTD) and recommended phase ll d
Externí odkaz:
https://doaj.org/article/b8aae7bffb54466fa8eea9b57abb925c
Autor:
Kyoungmin Lee, In Hae Park, Sang Cheul Oh, Jae Hong Seo, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul Won Choi, Ah‐reum Lim, Myung Han Hyun, Ju Won Kim, Jwa Hoon Kim, Yoon Ji Choi, Soohyeon Lee, Kyong Hwa Park, Yeul Hong Kim, Jung Yoon Choi, Jung Sun Kim, Se Ryeon Lee, Hwa Jung Sung, Eun Joo Kang
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 5558-5568 (2023)
Abstract Background Although various coronavirus disease 2019 (COVID‐19) vaccines have been delivered to the public worldwide, data on cancer populations are limited. Vaccine hesitancy related to safety concerns is observed among cancer patients. W
Externí odkaz:
https://doaj.org/article/83b3db34a8f04feb96bd35c297628170
Autor:
Ah Reum Lim, Chai Hong Rim
Publikováno v:
Medicina, Vol 59, Iss 11, p 1934 (2023)
Oligometastasis is defined as the presence of several limited metastatic lesions and is generally limited to three or fewer than five metastatic lesions. Previously, the treatment of metastatic cancer aimed to alleviate symptoms rather than cure them
Externí odkaz:
https://doaj.org/article/389afb0c3d014244ba523b84748bfdea
PIK3CA Mutation Is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients.
Autor:
Ju Won Kim1, Ah Reum Lim1, Ji Young You2, Jung Hyun Lee3, Sung Eun Song4, Nam Kwon Lee5, Seung Pil Jung2, Kyu Ran Cho4, Cheol Yong Kim5, Kyong Hwa Park1 khpark@korea.ac.kr
Publikováno v:
Cancer Research & Treatment. Apr2023, Vol. 55 Issue 2, p531-541. 11p.
Autor:
Ji Min Lee, Jin Hwa Hong, Soon Young Lim, Ju Won Kim, Ah Reum Lim, Myung Han Hyun, Kyong Hwa Park
Publikováno v:
Cancer Research. 83:P2-20
Human Epidermal growth factor Receptor 2 (HER2) is overexpressed in 20% to 30% of breast cancers and is associated with poor prognosis. Patients with advanced HER2-type breast cancer are treated with HER2-directed tyrosine kinase inhibitors as well a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bdb10fc455dc227fb93fd6e1a29c058
https://doi.org/10.1158/1538-7445.sabcs22-p2-20-04
https://doi.org/10.1158/1538-7445.sabcs22-p2-20-04
Autor:
Kyoungmin Lee, In Hae Park, Sang Cheul Oh, Jae Hong Seo, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul Won Choi, Ah‐reum Lim, Myung Han Hyun, Ju Won Kim, Jwa Hoon Kim, Yoon Ji Choi, Soohyeon Lee, Kyong Hwa Park, Yeul Hong Kim, Jung Yoon Choi, Jung Sun Kim, Se Ryeon Lee, Hwa Jung Sung, Eun Joo Kang
Publikováno v:
Cancer Medicine. 12:5558-5568
Although various coronavirus disease 2019 (COVID-19) vaccines have been delivered to the public worldwide, data on cancer populations are limited. Vaccine hesitancy related to safety concerns is observed among cancer patients. We report the perceptio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aae07dc7efe5ed7585edcaee46335d9
https://doi.org/10.1002/cam4.5400
https://doi.org/10.1002/cam4.5400
Publikováno v:
Supportive Care in Cancer. 30:8129-8137
Purpose First-line choice of therapy is critical as it affects treatment decisions in later lines in patients with metastatic colorectal cancer (mCRC). We assessed changes in renal function for 1 year among patients diagnosed with mCRC who received f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83721d765c30ba115bb48462453b908f
https://doi.org/10.1007/s00520-022-07249-2
https://doi.org/10.1007/s00520-022-07249-2